Fig. 1From: MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinomaFlowchart summarizes the tumor treatment evaluation process. The process begins with tumor implantation in a rat model, followed by the acquisition and processing of MRI images. Subsequently, radiomics features are extracted and fed into the MRI radiomics model. This model is designed to predict HCC treatment outcomes and establish correlations with histological biomarkersBack to article page